Sort
51,593 grants matching “hepatitis”
University of Washington Vaccine and Treatment Evaluation Unit
$1,863,350Anna Wald · University Of Washington · UM1 · FY2023 · AI
A-Z Clinical Trials Unit
$1,862,682Paul A. Goepfert · University Of Alabama At Birmingham · UM1 · FY2023 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,862,162University Of California San Francisco · U01 · FY2002 · AI
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$1,861,737Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2024 · AI
AIDS CLINICAL TRIALS GROUP - ACTU
$1,860,322University Of Cincinnati · U01 · FY2002 · AI
AIDS CLINICAL TRIALS GROUP - ACTU
$1,860,320University Of Cincinnati · U01 · FY2005 · AI
GENETICS OF ATHEROSCLEROSIS--ROLE OF INSULIN RESISTANCE
$1,859,298University Of California Los Angeles · P01 · FY2003 · HL
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$1,859,055Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Chimpanzee Biomedical Research Program Limited Competition (U42)
$1,858,987M. Babette Fontenot · University Of Louisiana At Lafayette · U42 · FY2012 · OD
Molecular Biology and Genetics of Human Tumor Viruses
$1,858,213William M. Sugden · University Of Wisconsin-Madison · P01 · FY2011 · CA
TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis
$1,858,106John Ramunas · Rejuvenation Technologies, Inc. · R44 · FY2024 · AA
CENTER FOR ALCOHOLIC LIVER AND PANCREATIC INJURY
$1,856,997University Of Southern California · P50 · FY2003 · AA
MOLECULAR BIOMARKERS FOR ENVIRONMENTAL TOXICANTS
$1,856,927John D Groopman · Johns Hopkins University · P01 · FY2008 · ES
Studies of HIV infection and its contribution to the natural history and outcome
$1,855,718Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Soluble epoxide hydrolase-regulated lipid signaling in Alzheimerâs disease
$1,855,051Izumi Maezawa · University Of California At Davis · RF1 · FY2021 · AG
Entry and replication of positive-sense, RNA viruses
$1,850,932Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity
$1,850,825D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2015 · TR
Molecular Biology and Genetics of Human Tumor Viruses
$1,850,672William M. Sugden · University Of Wisconsin-Madison · P01 · FY2012 · CA
New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency
$1,848,657David H Perlmutter · Washington University · P01 · FY2023 · DK
Functional Genomics and HCV-Associated Liver Disease
$1,848,035Michael G Katze · University Of Washington · P30 · FY2010 · DA
Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence
$1,847,427Fiona Marshall · Heptares Therapeutics, Ltd · R01 · FY2015 · DA
Liver Lung Interactions in Lung Inflammation
$1,847,206Vanderbilt University · P01 · FY2004 · HL
Molecular Biology and Genetics of Human Tumor Viruses
$1,846,989William M. Sugden · University Of Wisconsin-Madison · P01 · FY2008 · CA
CURE CTU
$1,845,017Stephen A Spector · University Of California, San Diego · UM1 · FY2025 · AI
Fully human recombinant therapeutic anti-vaccinia virus polyclonal antibody
$1,843,539Soren Bregenholt · Symphogen A/S · U01 · FY2007 · AI